The DOI matches its Crossref record; 146 of the 154 references it cites were found in a registry or an index.
Long-term effects of weight-reducing diets in people with hypertension
Open accessAbstract
BACKGROUND: All major guidelines for antihypertensive therapy recommend weight loss. Dietary interventions that aim to reduce body weight might therefore be a useful intervention to reduce blood pressure and adverse cardiovascular events associated with hypertension. OBJECTIVES: Primary objectives To assess the long-term effects of weight-reducing diets in people with hypertension on all-cause mortality, cardiovascular morbidity, and adverse events (including total serious adverse events, withdrawal due to adverse events, and total non-serious adverse events). Secondary objectives To assess the long-term effects of weight-reducing diets in people with hypertension on change from baseline in systolic blood pressure, change from baseline in diastolic blood pressure, and body weight reduction. SEARCH METHODS: For this updated review, the Cochrane Hypertension Information Specialist searched the following databases for randomised controlled trials up to April 2020: the Cochrane Hypertension Specialised Register, CENTRAL (2020, Issue 3), Ovid MEDLINE, Ovid Embase, and ClinicalTrials.gov. We also contacted authors of relevant papers about further published and unpublished work. The searches had no language restrictions. SELECTION CRITERIA: We included randomised controlled trials (RCTs) of at least 24 weeks' duration that compared weight-reducing dietary interventions to no dietary intervention in adults with primary hypertension. DATA COLLECTION AND ANALYSIS: , we used a random-effects model. MAIN RESULTS: This second review update did not reveal any new trials, so the number of included trials remains the same: eight RCTs involving a total of 2100 participants with high blood pressure and a mean age of 45 to 66 years. Mean treatment duration was 6 to 36 months. We judged the risks of bias as unclear or high for all but two trials. No study included mortality as a predefined outcome. One RCT evaluated the effects of dietary weight loss on a combined endpoint consisting of the necessity of reinstating antihypertensive therapy and severe cardiovascular complications. In this RCT, weight-reducing diet lowered the endpoint compared to no diet: hazard ratio 0.70 (95% confidence interval (CI) 0.57 to 0.87). None of the trials evaluated adverse events as designated in our protocol. The certainty of the evidence was low for a blood pressure reduction in participants assigned to weight-loss diets as compared to controls: systolic blood pressure: mean difference (MD) -4.5 mm Hg (95% CI -7.2 to -1.8 mm Hg) (3 studies, 731 participants), and diastolic blood pressure: MD -3.2 mm Hg (95% CI -4.8 to -1.5 mm Hg) (3 studies, 731 participants). We judged the certainty of the evidence to be high for weight reduction in dietary weight loss groups as compared to controls: MD -4.0 kg (95% CI -4.8 to -3.2) (5 trials, 880 participants). Two trials used withdrawal of antihypertensive medication as their primary outcome. Even though we did not consider this a relevant outcome for our review, the results of these RCTs strengthen the finding of a reduction of blood pressure by dietary weight-loss interventions. AUTHORS' CONCLUSIONS: In this second update, the conclusions remain unchanged, as we found no new trials. In people with primary hypertension, weight-loss diets reduced body weight and blood pressure, but the magnitude of the effects are uncertain due to the small number of participants and studies included in the analyses. Whether weight loss reduces mortality and morbidity is unknown. No useful information on adverse effects was reported in the relevant trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Weight-reducing diets are well established to lower BP among patients with hypertension, by 4.5/3.2 mm Hg in the most recent meta-analysis.347”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [347]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755
Flagged first, then by citations
8 of the 154 references couldn’t be matched to a known paper.
Research works printed but not linked: 76
- Anderssen, 1995, Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES), Blood Pressure, 4, 343, 10.3109/08037059509077619 · DOI
- Anderssen, 1996, Improved carbohydrate metabolism after physical training and dietary intervention in individuals with the 'atherothrombogenic syndrome'. Oslo Diet and Exercise Study (ODES). A randomized trial, Journal of Internal Medicine, 240, 203, 10.1046/j.1365-2796.1996.22848000.x · DOI · Paper page
- Jacobs, 2009, Association of 1-y changes in diet pattern with cardiovascular disease risk factors and adipokines: results from the 1-y randomized Oslo Diet and Exercise Study, The American Journal of Clinical Nutrition, 89, 509, 10.3945/ajcn.2008.26371 · DOI
- Torjesen, 1997, Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial, Diabetes Care, 20, 26, 10.2337/diacare.20.1.26 · DOI
- Urdal, 1993, The Oslo Diet and Exercise Study (ODES): Design and objectives, Controlled Clinical Trials, 14, 229, 10.1016/0197-2456(93)90005-X · DOI
- Anderssen, 1995, Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES), Blood Pressure, 4, 343, 10.3109/08037059509077619 · DOI
- Anderssen, 1996, Improved carbohydrate metabolism after physical training and dietary intervention in individuals with the 'atherothrombogenic syndrome'. Oslo Diet and Exercise Study (ODES). A randomized trial, Journal of Internal Medicine, 240, 203, 10.1046/j.1365-2796.1996.22848000.x · DOI · Paper page
- Jacobs, 2009, Association of 1-y changes in diet pattern with cardiovascular disease risk factors and adipokines: results from the 1-y randomized Oslo Diet and Exercise Study, The American Journal of Clinical Nutrition, 89, 509, 10.3945/ajcn.2008.26371 · DOI
- Torjesen, 1997, Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial, Diabetes Care, 20, 26, 10.2337/diacare.20.1.26 · DOI
- Urdal, 1993, The Oslo Diet and Exercise Study (ODES): Design and objectives, Controlled Clinical Trials, 14, 229, 10.1016/0197-2456(93)90005-X · DOI
- Wassertheil-Smoller, 1994, The trial of antihypertensive interventions and management (TAIM), Nieren- und Hochdruckkrankheiten, 23 (Suppl 1), S22
- Wassertheil-Smoller, 1991, The TAIM Study: Sex-race differences in effects of diet and drugs on cardiovascular risk, Cardiovascular Risk Factors, 1, 427
- Blaufox, 1992, Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy, JAMA, 267, 1221, 10.1001/jama.1992.03480090069029 · DOI
- Davis, 1989, Trial of antihypertensive interventions and management. Design, methods, and selected baseline results, Controlled Clinical Trials, 10, 11, 10.1016/0197-2456(89)90016-0 · DOI
- Davis, 1992, Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group, Hypertension, 19, 393, 10.1161/01.HYP.19.4.393 · DOI
- Davis, 1994, Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management, American Journal of Hypertension, 7, 926, 10.1093/ajh/7.10.926 · DOI
- Langford, 1991, Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group, Hypertension, 17, 210, 10.1161/01.HYP.17.2.210 · DOI
- Oberman, 1990, Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status, Annals of Internal Medicine, 112, 89, 10.7326/0003-4819-112-2-89 · DOI
- Wassertheil-Smoller, 1994, The trial of antihypertensive interventions and management (TAIM), Nieren- und Hochdruckkrankheiten, 23 (Suppl 1), S22
- Wassertheil-Smoller, 1991, The TAIM Study: Sex-race differences in effects of diet and drugs on cardiovascular risk, Cardiovascular Risk Factors, 1, 427
- Wassertheil-Smoller, 1992, The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life, American Journal of Hypertension, 5, 37, 10.1093/ajh/5.1.37 · DOI
- Wylie-Rosett, 1993, Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention, Journal of the American Dietetic Association, 93, 408, 10.1016/0002-8223(93)92286-7 · DOI
- Blaufox, 1992, Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy, JAMA, 267, 1221, 10.1001/jama.1992.03480090069029 · DOI
- Davis, 1989, Trial of antihypertensive interventions and management. Design, methods, and selected baseline results, Controlled Clinical Trials, 10, 11, 10.1016/0197-2456(89)90016-0 · DOI
- Davis, 1993, Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension, Archives of Internal Medicine, 153, 1773, 10.1001/archinte.1993.00410150051005 · DOI
- Davis, 1992, Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group, Hypertension, 19, 393, 10.1161/01.HYP.19.4.393 · DOI
- Davis, 1994, Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management, American Journal of Hypertension, 7, 926, 10.1093/ajh/7.10.926 · DOI
- Langford, 1991, Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group, Hypertension, 17, 210, 10.1161/01.HYP.17.2.210 · DOI
- Oberman, 1990, Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status, Annals of Internal Medicine, 112, 89, 10.7326/0003-4819-112-2-89 · DOI
- Wassertheil-Smoller, 1994, The trial of antihypertensive interventions and management (TAIM), Nieren- und Hochdruckkrankheiten, 23 (Suppl 1), S22
- Wassertheil-Smoller, 1992, The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension, Archives of Internal Medicine, 152, 131, 10.1001/archinte.1992.00400130141018 · DOI
- Wassertheil-Smoller, 1991, The TAIM Study: Sex-race differences in effects of diet and drugs on cardiovascular risk, Cardiovascular Risk Factors, 1, 427
- Wassertheil-Smoller, 1992, The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life, American Journal of Hypertension, 5, 37, 10.1093/ajh/5.1.37 · DOI
- Wylie-Rosett, 1993, Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention, Journal of the American Dietetic Association, 93, 408, 10.1016/0002-8223(93)92286-7 · DOI
- Blaufox, 1992, Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy, JAMA, 267, 1221, 10.1001/jama.1992.03480090069029 · DOI
- Davis, 1989, Trial of antihypertensive interventions and management. Design, methods, and selected baseline results, Controlled Clinical Trials, 10, 11, 10.1016/0197-2456(89)90016-0 · DOI
- Davis, 1993, Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension, Archives of Internal Medicine, 153, 1773, 10.1001/archinte.1993.00410150051005 · DOI
- Davis, 1992, Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group, Hypertension, 19, 393, 10.1161/01.HYP.19.4.393 · DOI
- Davis, 1994, Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management, American Journal of Hypertension, 7, 926, 10.1093/ajh/7.10.926 · DOI
- Langford, 1991, Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group, Hypertension, 17, 210, 10.1161/01.HYP.17.2.210 · DOI
- Oberman, 1990, Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status, Annals of Internal Medicine, 112, 89, 10.7326/0003-4819-112-2-89 · DOI
- Wassertheil-Smoller, 1994, The trial of antihypertensive interventions and management (TAIM), Nieren- und Hochdruckkrankheiten, 23 (Suppl 1), S22
- Wassertheil-Smoller, 1992, The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension, Archives of Internal Medicine, 152, 131, 10.1001/archinte.1992.00400130141018 · DOI
- Wassertheil-Smoller, 1991, The TAIM Study: Sex-race differences in effects of diet and drugs on cardiovascular risk, Cardiovascular Risk Factors, 1, 427
- Wassertheil-Smoller, 1992, The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life, American Journal of Hypertension, 5, 37, 10.1093/ajh/5.1.37 · DOI
- Wylie-Rosett, 1993, Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention, Journal of the American Dietetic Association, 93, 408, 10.1016/0002-8223(93)92286-7 · DOI
- Blaufox, 1992, Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy, JAMA, 267, 1221, 10.1001/jama.1992.03480090069029 · DOI
- Davis, 1989, Trial of antihypertensive interventions and management. Design, methods, and selected baseline results, Controlled Clinical Trials, 10, 11, 10.1016/0197-2456(89)90016-0 · DOI
- Davis, 1993, Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension, Archives of Internal Medicine, 153, 1773, 10.1001/archinte.1993.00410150051005 · DOI
- Davis, 1992, Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group, Hypertension, 19, 393, 10.1161/01.HYP.19.4.393 · DOI
- Davis, 1994, Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management, American Journal of Hypertension, 7, 926, 10.1093/ajh/7.10.926 · DOI
- Langford, 1991, Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group, Hypertension, 17, 210, 10.1161/01.HYP.17.2.210 · DOI
- Oberman, 1990, Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status, Annals of Internal Medicine, 112, 89, 10.7326/0003-4819-112-2-89 · DOI
- Wassertheil-Smoller, 1994, The trial of antihypertensive interventions and management (TAIM), Nieren- und Hochdruckkrankheiten, 23 (Suppl 1), S22
- Wassertheil-Smoller, 1992, The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension, Archives of Internal Medicine, 152, 131, 10.1001/archinte.1992.00400130141018 · DOI
- Wassertheil-Smoller, 1991, The TAIM Study: Sex-race differences in effects of diet and drugs on cardiovascular risk, Cardiovascular Risk Factors, 1, 427
- Wassertheil-Smoller, 1992, The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life, American Journal of Hypertension, 5, 37, 10.1093/ajh/5.1.37 · DOI
- Wylie-Rosett, 1993, Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention, Journal of the American Dietetic Association, 93, 408, 10.1016/0002-8223(93)92286-7 · DOI
- Bahnson, 1997, Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE), Disease Management & Clinical Outcomes, 1, 61, 10.1016/S1088-3371(97)00005-3 · DOI
- Fessler, 1998, Sodium reduction and weight loss instead of treatment with antihypertensive agents. [German], Deutsche Apotheker Zeitung, 138, 36
- Hypertension Prevention Collaborative Research Group, 1993, The impact of weight loss on blood pressure, Patient Care, 27, 16
- Angelico, 2009, Low-fat, low-calorie, Mediterranean-style diet improves endothelial dysfunction in patients with the metabolic syndrome, Journal of Diabetes, 1, A43
- Appel, 2006, The effects of macronutrient intake on blood pressure: Subgroup analyses from the OmniHeart randomized feeding study, Journal of Hypertension, 24, 177
- Bao, 1999, Dietary fish and weight reduction improves multiple risk factors in overweight, treated hypertensives. [abstract], Australian & New Zealand Journal of Medicine, 29, 148
- Bouchonville, 2012, Weight Loss, Exercise, or Both and Cardiometabolic Risk Factors in Obese Older Adults: Results of a Randomized Controlled Trial, Endocrine Reviews, 33, S18, 10.1038/ijo.2013.122 · DOI · Paper page
- Cambien, 1986, Comparative study of a medical and a dietary intervention in overweight hypertensive patients, Archives des Maladies du Coeur et des Vaisseaux, 79, 1002
- Ebell, 2013, Intensive lifestyle intervention fails to improve patient-oriented outcomes in persons with obesity and diabetes, American Family Physician, 88, 864A
- Hayward, 2010, Lifestyle modification and NAFLD: A prospective, randomized trial, Hepatology, 52, 622A
- Masuo, 2012, The effects of weight loss on liver function in obese hypertensive patients, Circulation, 125, P131
- McCarron, 2000, Cardiovascular risk reduction dietary intervention trial, Drug Benefit Trends, 12, 42
- Tate, 2011, Replacing caloric beverages with water or diet beverages for weight loss in adults: Results of a 6-month randomized controlled trial, Obesity, 19, S68
- Tunyan, 2007, Cardioprotective effects of antihypertensive therapy with orlistat treatment and hypocaloric diet in combination in obese hypertensive patients, Circulation, 115, e248
- Anderssen, 1995, Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES), Blood Pressure, 4, 343, 10.3109/08037059509077619 · DOI
- Haynes B RE: Cochrane Review [personal communication] Email to: A Siebenhofer.
- The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014
- Urdal, 1993, The Oslo Diet and Exercise Study (ODES): Design and objectives, Controlled Clinical Trials, 14, 229, 10.1016/0197-2456(93)90005-X · DOI
Cited by
Sorted by citations
Items 101–118 of 118
Manolis, A. J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734299250.793571584 · Cited by 1
Risk Factors of Hypertension in Low- and Middle-income Countries: A Prompt Portray
Ahmad, R., Sinha, S., Chowdhury, K., & Haque, M. (2024) · Advances in Human Biology · doi:10.4103/aihb.aihb_56_24 · Cited by 1
Roy, S. (2019) · Clinical Diabetology · doi:10.5603/dk.2019.0020
“There is a decrease in blood pressure of ~1 mm Hg with the loss in body weight by 1 kg [4].”
BackgroundEffect of diet-induced weight loss on osteoarthritic knee pain
Sept, L., & Korownyk, C. S. (2022) · Canadian Family Physician · doi:10.46747/cfp.6802113
Effet de la perte pondérale résultant d’un régime sur la douleur arthrosique du genou
Sept, L., & Korownyk, C. S. (2022) · Canadian Family Physician · doi:10.46747/cfp.6802e29
AÇÃO DOS ISGLT2 NO HIPERTENSO DIABÉTICO, QUANDO INDICAR?
Bianco, H. T. (2021) · Revista Brasileira de Hipertensão · doi:10.47870/1519-7522/20212804283-7
Çapar, A. G., & Yılmaz, M. (2022) · Research Square · doi:10.21203/rs.3.rs-2056603/v1
Pharmacotherapy of Obesity: An Updated Overview
Hussein, M. T. E., & Favell, D. (2023) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2023.104750
Xu, M., Мамедова, Л. В., & VAKOLYUK, R. M. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00885
Ruzive, S., Theunissen, H., Durão, S., Visser, M. E., & Naude, C. E. (2024) · Cochrane Evidence Synthesis and Methods · doi:10.1002/cesm.12048
Hausärztliche Aspekte in der Bluthochdrucktherapie
Bleckwenn, M. (2024) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-024-3678-9
Langley-Evans, S. (2021) · Wiley eBooks · doi:10.1002/9781119717577.ch8
Okazaki, M., Katsuki, T., Kurata, H., Tanaka, S., Tanaka, H., & Kawai, T. (2025) · Journal of General and Family Medicine · doi:10.1002/jgf2.70031
“14,15 However, previous reports have followed up for several years or more, whereas this study was evaluated at a short-term point of 3 months.”
Goupil, R., Tsuyuki, R. T., Santesso, N. A., Terenzi, K. A., Habert, J., Cheng, G., Gysel, S. C., Bruneau, J., Leung, A. A. C., Campbell, N. R. C., et al. (2025) · Canadian Medical Association Journal · doi:10.1503/cmaj.241770-f
“…dont l’HTA nécessite un traitement phar - macologique, nous recommandons d’instaurer d’emblée un traitement d’association (idéalement en monocomprimé) qui combine un IECA ou un ARA et soit un diurétique thi - azidique ou de type thiazidique soit un BCC dihydropyridi - nique à longue durée d’action.”
‘4 Ss’ for successful blood pressure control
Wilkinson, I. B., Partridge, S., & Sever, P. (2025) · Journal of Hypertension · doi:10.1097/hjh.0000000000004054
“Weight reduction is an effective method of BP lowering but is difficult to achieve and maintain [11].”
Goupil, R., Tsuyuki, R. T., Santesso, N. A., Terenzi, K. A., Habert, J., Cheng, G., Gysel, S. C., Bruneau, J., Leung, A. A. C., Campbell, N. R. C., et al. (2025) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/17151635251352537
Ameliorative effects of Saussurea lappa against hypertension and anxiety in animal models
Gaur, A., Mazumder, A., Das, S., Raghuvanshi, S., & Sinha, A. (2026) · Indian Journal of Physiology and Pharmacology · doi:10.25259/ijpp_290_2025
Metadata
- Authors
- Semlitsch, T., Jeitler, K., Berghold, A., Horvath, K., Posch, N., Poggenburg, S., & Siebenhofer, A.
- Affiliations
- Medical University of Graz (AT)
- Goethe University Frankfurt (DE)
- ORCID
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2016-03-02
- Volume
- 2
- Pages
- CD008274-CD008274
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- PMC
- PMC7154764
- OpenAlex
- W2290414732
- Cited by
- 118
- References
- 154
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 10 · 2023: 10 · 2022: 15 · 2021: 18 · 2020: 16 · 2019: 16 · 2018: 10 · 2017: 9 · 2016: 2
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Update notices
- new_version (2021-02-08)
- Open access
- bronze
- doi.org
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Keywords
- hypertension, weight loss diet, dietary weight loss, blood pressure reduction, cardiovascular morbidity, all-cause mortality, adverse events, weight loss, antihypertensive therapy, essential hypertension, long-term effects, cardiovascular complications, antihypertensive withdrawal, risk of bias, quality of evidence
- MeSH terms
- Aged, Blood Pressure, Cardiovascular Diseases, Diet, Reducing, Humans, Hypertension, Middle Aged, Weight Loss, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review